Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.24
Bid: 27.08
Ask: 27.20
Change: -0.30 (-1.09%)
Spread: 0.12 (0.443%)
Open: 27.54
High: 27.60
Low: 27.08
Prev. Close: 27.24
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Hammerson PLC

29 Mar 2018 07:01

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Carlson Capital, L.P.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hammerson plc (GB0004065016)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

March 28 2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES / NO / N/A

If YES, specify which:

Yes. Intu Properties plc (GB0006834344)

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Class: 25p ordinary

ISIN: GB0004065016

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: -292,088 -.03677%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

-292,088 -.03677%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(GBP gross)

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(GBP net)

25p Ordinary Actively Traded Swap Decreasing a Short Position 109,861 5.406782
25p Ordinary Actively Traded Swap Decreasing a Short Position 109,850 5.350273
25p Ordinary CFD Decreasing a Short Position 390,150 5.350273
25p Ordinary CFD Decreasing a Short Position 390,139 5.406782

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES/NO

No

Date of disclosure: March 29 2018
Contact name: Luis Contreras
Telephone number: 214 932 9608

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180328006133/en/

Copyright Business Wire 2018

Date   Source Headline
18th Aug 20233:00 pmRNSHolding(s) in Company
14th Aug 20239:30 amRNSDividend Currency Conversion Announcement
10th Aug 20233:00 pmRNSHolding(s) in Company
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events
18th Aug 202212:15 pmRNSHolding(s) in Company
28th Jul 20227:01 amRNSDividend Declaration
28th Jul 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.